Theratechnologies Inc
TSX:TH
Theratechnologies Inc
TSX:TH
Price:
1.78 CAD
7.23%
Market Closed
Updated:
May 14, 2024
Theratechnologies Inc
Gross Profit
|
Theratechnologies Inc
Gross Profit Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Theratechnologies Inc
TSX:TH
|
Gross Profit
$57.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
36%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Gross Profit
$169.9m
|
CAGR 3-Years
480%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
68%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Gross Profit
CA$662k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-10%
|
See Also
What is Theratechnologies Inc's Gross Profit?
Gross Profit
57.9m
USD
57.9m
USD
Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Gross Profit amounts to 57.9m USD.
What is Theratechnologies Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
36%
36%
Over the last year, the Gross Profit growth was 2%. The average annual Gross Profit growth rates for Theratechnologies Inc have been 14% over the past three years , 11% over the past five years , and 36% over the past ten years .
You don't have any saved screeners yet
